These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33492440)

  • 1. The triglycerides and glucose index is strongly associated with hepatic steatosis in children with overweight or obesity.
    Simental-Mendía LE; Ortega-Pacheco CJ; García-Guerrero E; Sicsik-Aragón MA; Guerrero-Romero F; Martínez-Aguilar G
    Eur J Pediatr; 2021 Jun; 180(6):1755-1760. PubMed ID: 33492440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 3. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
    Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
    Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The triglycerides and glucose index is highly associated with non-alcoholic fatty liver disease in overweight and obese women.
    Rodríguez-Hernández H; Simental-Mendía LE
    Ir J Med Sci; 2023 Dec; 192(6):2741-2746. PubMed ID: 36928593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.
    Lee SB; Kim MK; Kang S; Park K; Kim JH; Baik SJ; Nam JS; Ahn CW; Park JS
    Endocrinol Metab (Seoul); 2019 Jun; 34(2):179-186. PubMed ID: 31257745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
    Kitae A; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Can J Gastroenterol Hepatol; 2019; 2019():5121574. PubMed ID: 31687367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus.
    Malek M; Khamseh ME; Chehrehgosha H; Nobarani S; Alaei-Shahmiri F
    Endocrine; 2021 Dec; 74(3):538-545. PubMed ID: 34355342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: a retrospective cohort study in China.
    Huanan C; Sangsang L; Amoah AN; Yacong B; Xuejiao C; Zhan S; Guodong W; Jian H; Songhe S; Quanjun L
    BMJ Open; 2020 Nov; 10(11):e039804. PubMed ID: 33247011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride/glucose index is a reliable alternative marker for insulin resistance in South American overweight and obese children and adolescents.
    Locateli JC; Lopes WA; Simões CF; de Oliveira GH; Oltramari K; Bim RH; de Souza Mendes VH; Remor JM; Lopera CA; Nardo Junior N
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1163-1170. PubMed ID: 31472061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity.
    Medrano M; Arenaza L; Migueles JH; Rodríguez-Vigil B; Ruiz JR; Labayen I
    Pediatr Diabetes; 2020 Jun; 21(4):565-574. PubMed ID: 32237015
    [TBL] [Abstract][Full Text] [Related]  

  • 13.  The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women.
    Simental-Mendía LE; Simental-Mendía E; Rodríguez-Hernández H; Rodríguez-Morán M; Guerrero-Romero F
    Ann Hepatol; 2016; 15(5):715-20. PubMed ID: 27493110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin Resistance Markers to Detect Nonalcoholic Fatty Liver Disease in a Male Hispanic Population.
    Pérez-Mayorga M; Lopez-Lopez JP; Chacon-Manosalva MA; Castillo MG; Otero J; Martinez-Bello D; Gomez-Arbelaez D; Cohen DD; Lopez-Jaramillo P
    Can J Gastroenterol Hepatol; 2022; 2022():1782221. PubMed ID: 35966932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects.
    Zhang S; Du T; Li M; Jia J; Lu H; Lin X; Yu X
    Medicine (Baltimore); 2017 Jun; 96(22):e7041. PubMed ID: 28562560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents.
    Netaji A; Jain V; Gupta AK; Kumar U; Jana M
    J Pediatr Endocrinol Metab; 2020 Apr; 33(4):473-479. PubMed ID: 32146441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience.
    Scicali R; Di Pino A; Urbano F; Ferrara V; Marchisello S; Di Mauro S; Scamporrino A; Filippello A; Rabuazzo AM; Purrello F; Piro S
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):869-879. PubMed ID: 33549441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.